Evidence map›Paper›PMID 37582966›Full record

ArticleScientific reports2023

Mammography using low-frequency electromagnetic fields with deep learning.

Hamid Akbari-Chelaresi, Dawood Alsaedi, Seyed Hossein Mirjahanmardi, Mohamed El Badawe, Ali M Albishi, Vahid Nayyeri, Omar M Ramahi

Abstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hamid Akbari-ChelaresiDepartment of Electrical and Computer Engineering, University of Waterloo, Waterloo, ON, N2L 3G1, Canada.
Dawood AlsaediDepartment of Electrical Engineering, Taif University, 26571, Taif, Saudi Arabia.
Seyed Hossein MirjahanmardiDepartment of Medical Physics, Stanford University, Stanford, CA, 94304, USA.
Mohamed El BadaweSoundskrit Inc., 1751 Rue Richardson, No. 5102, Montreal, Canada.
Ali M AlbishiElectrical Engineering Department, King Saud University, 11421, Riyadh, Saudi Arabia.
Vahid NayyeriSchool of Advanced Technologies, Iran University of Science and Technology, Tehran, 16846-13114, Iran. nayyeri@iust.ac.ir.
Omar M RamahiDepartment of Electrical and Computer Engineering, University of Waterloo, Waterloo, ON, N2L 3G1, Canada. oramahi@uwaterloo.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this paper, a novel technique for detecting female breast anomalous tissues is presented and validated through numerical simulations. The technique, to a high degree, resembles X-ray mammography; however, instead of using X-rays for obtaining images of the breast, low-frequency electromagnetic fields are leveraged. To capture breast impressions, a metasurface, which can be thought of as analogous to X-rays film, has been employed. To achieve deep and sufficient penetration within the breast tissues, the source of excitation is a simple narrow-band dipole antenna operating at 200 MHz. The metasurface is designed to operate at the same frequency. The detection mechanism is based on comparing the impressions obtained from the breast under examination to the reference case (healthy breasts) using machine learning techniques. Using this system, not only would it be possible to detect tumors (benign or malignant), but one can also determine the location and size of the tumors. Remarkably, deep learning models were found to achieve very high classification accuracy.

Indexed as

Deep LearningBreastElectromagnetic FieldsFemaleHumansMachine LearningMammography

Identifiers

PMID37582966
PMCPMC10427672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.